RecruitingNot ApplicableNCT06359964
Infective Complications in TP Biopsy Without Antibiotic Prophylaxis
Infective Complications in Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Prospective Cohort Study
Sponsor
Chinese University of Hong Kong
Enrollment
1,900 participants
Start Date
Aug 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study is a prospective cohort study to delineate the infective outcomes and incidence after transperineal prostate biopsy with no antibiotic prophylaxis, compared to the existing data on outcomes on patients receiving transperineal prostate biopsy with antibiotic prophylaxis.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria7
- All consecutive patients in participating centres receiving transperineal USG-guided biopsy for any indication including:
- Elevated PSA
- Abnormal DRE
- Follow-up biopsy in active surveillance
- Suspicion of CAP recurrence after radiotherapy
- Follow-up biopsy after focal therapy
- Consenting to the study
Exclusion Criteria7
- Recent suspected UTI within 1 month
- Recent culture proven bacteriuria within 1 month
- History of recurrent UTI
- Indwelling urinary catheter
- Immunocompromised state
- High risk of infective endocarditis (including prosthetic heart valve, congenital heart disease, or previous history of infective endocarditis
- Incompetent or incapable of understanding the nature of the study or giving informed consent
Interventions
PROCEDURETransperineal Biopsy without antibiotics prophylaxis
Transperineal Biopsy without antibiotics prophylaxis
PROCEDURETransperineal Biopsy with antibiotics prophylaxis
Transperineal Biopsy with antibiotics prophylaxis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06359964
Related Trials
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT0678067052 locations